StoneX Group’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
VCM
VPM
StoneX Group's AMGN Position: Q1 2026 in Review
StoneX Group reduced its Amgen (AMGN) stake by 38% in Q1 2026, selling an estimated $2.45M and leaving 11,188 shares worth $3.94M. The position accounts for 0.21% of the portfolio, ranked #82.
StoneX Group first reported a position in AMGN in Q2 2017 and has held it in 27 quarters since. The position peaked at $5.91M in Q4 2025. 3,127 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.
- StoneX Group held 11,188 shares of Amgen worth $3.94M as of Q1 2026.
- StoneX Group sold 6,876 Amgen shares in Q1 2026, an estimated $2.45M.
- Amgen made up 0.21% of StoneX Group's portfolio in Q1 2026, its #82 holding.
- StoneX Group first reported a position in Amgen in Q2 2017 and has held it in 27 quarters since.
- StoneX Group's Amgen position peaked at $5.91M in Q4 2025.
- 3,127 funds tracked by Wall St. Rank held Amgen as of Q1 2026.
Based on StoneX Group's 13F filing for Q1 2026, filed 14 May 2026.